4.530USD-2.05%Mkt Cap: 255.45M USDP/E: —Last update: 2026-06-01
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigatio…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap255.45M USD
Enterprise Value129.46M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-57.44M USD
Revenue/Share—
Last Price4.530 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees46
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS74365U1079
Valuation
P/E (Trailing)—
P/E (Forward)-3.03
PEG—
EV/EBITDA-1.86
EV/Revenue—
P/S—
P/B1.27
EPS (TTM)-1.36
EPS (Forward)-1.53
52W Range
2.77035% of range7.820
52W High7.820 USD
52W Low2.770 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-29.24%
ROA-27.42%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-56.37M USD
CapEx (TTM)94.00K USD
FCF Margin—
FCF Yield-15.40%
Net Debt-132.73M USD
Net Debt/EBITDA1.90
Balance Sheet
Debt/Equity0.02
Current Ratio15.69
Quick Ratio15.39
Book Value/Sh3.665 USD
Cash/Share2.416 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 10, 2020
Splits
Last Split1:40
Split DateJan 10, 2020
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)26.57 USD
Target Range24.00 USD – 30.00 USD
# Analysts7
Ownership
Shares Out.56.20M
Float49.48M
Insiders2.39%
Institutions82.36%
Short Interest
Short Ratio5.8d
Short % Float6.77%
Short % Out.6.65%
Shares Short3.74M
Short (prev mo.)5.75M
Technical
SMA 505.121 (-11.5%)
SMA 2005.200 (-12.9%)
Beta1.52
S&P 52W Chg27.70%
Avg Vol (30d)721.16K
Avg Vol (10d)977.87K
Technical Indicators
RSI (14)41.1
MACD-0.1566
MACD Signal-0.1245
MACD Hist.-0.0321
BB Upper5.747 USD
BB Middle5.046 USD
BB Lower4.344 USD
BB Width27.80%
ATR (14)0.3008 USD
Vol Ratio (20d)0.50x